Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS
British Journal of Haematology (2016)
  • Raya Mawad, Fred Hutchinson Cancer Research Center
  • Pamela S. Becker, Fred Hutchinson Cancer Research Center
  • Paul Hendrie, Fred Hutchinson Cancer Research Center
  • Bart Scott, Fred Hutchinson Cancer Research Center
  • Brent L. Wood, Fred Hutchinson Cancer Research Center
  • Carol Dean, Fred Hutchinson Cancer Research Center
  • Vicky Sandhu, Fred Hutchinson Cancer Research Center
  • Hans Joachim Deeg, Fred Hutchinson Cancer Research Center
  • Roland Walter, Fred Hutchinson Cancer Research Center
  • Lixia Wang, Eli Lilly and Company
  • Han Myint, Rush University Medical Center
  • Jack W. Singer, University of Washington
  • Elihu Estey, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
January 1, 2016
DOI
10.1111/bjh.13829
Citation Information
Raya Mawad, Pamela S. Becker, Paul Hendrie, Bart Scott, et al.. "Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS" British Journal of Haematology Vol. 172 Iss. 2 (2016) p. 238 - 245
Available at: http://works.bepress.com/john-pagel/46/